NYU Langone Health Mar 5 2025 Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is obesity a known risk factor for diabetes, but it also increases risk of postsurgical complications, such as inflammation , organ rejection, and early death. Previous research had suggested some benefit for kidney transplant recipients with a history of type 2 diabetes who